| Literature DB >> 15250120 |
Jeffrey P Kahn1, Anna C Mastroianni.
Abstract
During the nearly 10 years since its introduction, preimplantation genetic diagnosis (PGD) has been used predominantly to avoid giving birth to a child with identified genetic disease. Recently, PGD was used by a couple not only to test IVF-created embryos for genetic disease, but also to test for a nondisease trait related to immune compatibility with a child in the family in need of an hematropoetic stem cell transplant. This article describes the case, raises some ethical and policy issues, highlights gaps in U.S. policy, and finally makes some recommendations for addressing advancing genetic and reproductive technologies.Entities:
Keywords: Analytical Approach; Genetics and Reproduction
Mesh:
Year: 2004 PMID: 15250120 DOI: 10.1353/ken.2004.0017
Source DB: PubMed Journal: Kennedy Inst Ethics J ISSN: 1054-6863